BeOne

BeOne Medicines Ltd. is a global biotechnology company rooted in science, focusing on developing innovative and affordable drugs to improve treatment outcomes and enhance drug accessibility for patients worldwide. The company currently has a broad portfolio of over 40 clinical candidates. By strengthening its independent R&D capabilities and partnerships, BeiGene accelerates the development of a diverse and innovative drug pipeline. We are committed to comprehensively improving drug accessibility for more than 2 billion people globally by 2030. BeiGene has built a team of over 7,700 employees across five continents.